← Back to guidelines
Cardiology15 papers

Viral posterior uveitis

Last edited: 4/22/2026

Overview

Viral posterior uveitis involves inflammation of the posterior segment of the eye, often affecting the retina and choroid, leading to visual impairment and potential complications such as retinal vasculitis. 12

Diagnosis

  • Clinical examination: Essential for initial assessment, though limited in detecting subtle vasculitis. 1
  • Staurenghi lens angiography (SLA): Provides enhanced visualization of retinal vasculitis, aiding in diagnosis and monitoring disease activity. Useful in detecting subclinical vasculitis in 31% of cases. 1
  • Anti-retinal antibodies: Presence of autoantibodies against photoreceptor outer segments and Müller cells may indicate retinal autoimmunity in conditions like Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. 2
  • Management

  • Immunosuppressive therapy: First-line treatment often includes corticosteroids (dose varies based on severity) and immunomodulatory agents like methotrexate or mycophenolate mofetil to control inflammation. 12 (Evidence: Expert opinion)
  • Monitoring and adjustment: Regular use of SLA to monitor disease activity and adjust immunosuppressive therapy accordingly. 1 (Evidence: Moderate)
  • Laser photocoagulation: Considered in cases where neovascularization or leakage is identified, guided by imaging modalities like SLA. 1 (Evidence: Moderate)
  • Special Populations

  • No specific data provided: Abstracts do not cover unique considerations for pregnancy, pediatrics, elderly, or comorbidities in viral posterior uveitis management. 12
  • Key Recommendations

  • Utilize Staurenghi lens angiography for enhanced diagnosis and monitoring of retinal vasculitis in posterior uveitis, particularly to detect subclinical involvement. (Evidence: Moderate) 1
  • Consider anti-retinal antibody testing in complex cases of posterior uveitis to evaluate for underlying autoimmune mechanisms, especially in suspected Vogt-Koyanagi-Harada syndrome, Behcet's disease, or sympathetic ophthalmia. (Evidence: Moderate) 2
  • Regularly adjust immunosuppressive therapy based on imaging findings, such as those obtained from Staurenghi lens angiography, to manage disease activity effectively. (Evidence: Expert opinion) 1
  • References

    1 Reeves GM, Kumar N, Beare NA, Pearce IA. Use of Staurenghi lens angiography in the management of posterior uveitis. Acta ophthalmologica 2013. link 2 Chan CC, Palestine AG, Nussenblatt RB, Roberge FG, Benezra D. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology 1985. link33911-8)

    Original source

    1. [1]
      Use of Staurenghi lens angiography in the management of posterior uveitis.Reeves GM, Kumar N, Beare NA, Pearce IA Acta ophthalmologica (2013)
    2. [2]
      Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia.Chan CC, Palestine AG, Nussenblatt RB, Roberge FG, Benezra D Ophthalmology (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG